Prescription medicine
Griseofulvin
Griseofulvin is a prescription medicine. FDA's NDC Directory lists it from 10 generic labelers, and pharmacies paid $3.74 per griseofulvin ultra 250 mg tablet in the October 7, 2026 NADAC survey.
- Generic listed
Check it at the source: the griseofulvin FDA label on DailyMed (effective December 10, 2025); every griseofulvin label on DailyMed.
Highlights of the record
FDA label of December 10, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026
Used for
From the label: indications and usageUltramicrosize griseofulvin tablets are indicated for the treatment of the following ringworm infections;
Forms and strengths
- 125 mg
- 165 mg
- 250 mg
- 500 mg
- 125 mg/5ml
Tablet; suspension; coated tablet.
On the market
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 10 of which 10 under generic applications, 0 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- $3.74 per tablet Griseofulvin ultra 250 mg tablet
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 286 through July 30, 2026
What is griseofulvin used for?
From the label: indications and usageUltramicrosize griseofulvin tablets are indicated for the treatment of the following ringworm infections; tinea corporis (ringworm of the body), tinea pedis (athlete’s foot), tinea cruris (ringworm of the groin and thigh), tinea barbae (barber’s itch), tinea capitis (ringworm of the scalp), and tinea unguium (onychomycosis, ringworm of the nails), when caused by one or more of the following genera of fungi: Trichophyton rubrum, Trichophyton tonsurans, Trichophyton mentagrophytes, Trichophyton interdigitalis, Trichophyton verrucosum, Trichophyton megnini, Trichophyton gallinae, Trichophyton crateriform, Trichophyton sulphureum, Trichophyton schoenleini, Microsporum audouini, Microsporum canis, Microsporum gypseum and Epidermophyton floccosum. […]
Conditions named in the indications of griseofulvin's FDA labels, with every medicine labeled for each:
From other griseofulvin labelsFungal infections: INDICATIONS Ultramicrosize griseofulvin tablets are indicated for the treatment of ringworm infections of the skin, hair, and nails, namely: tinea corporis, tinea pedis, tinea cruris, tinea barbae, tinea capitis, tinea unguium …
FDA pharmacologic class: Tubulin Inhibiting Agent.
Source: FDA drug label (Ultramicrosize Griseofulvin), Chartwell RX, LLC., effective December 10, 2025 (SPL set efb8a660-802c-4ca6-bbff-ad7b48b91aef), via openFDA; the full label on DailyMed
Is there a generic for griseofulvin?
No generic griseofulvin is approved (Drugs@FDA, October 8, 2026).
FDA's NDC Directory lists griseofulvin from 10 labelers under a generic (ANDA) application. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do pharmacies pay for griseofulvin?
In CMS's NADAC survey of October 7, 2026, pharmacies paid $3.74 per Griseofulvin ultra 250 mg tablet, down 12% from $4.24 on October 8, 2025. Prices per unit in the table differ many-fold by strength, form and brand, so compare like with like. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.
- Griseofulvin ultra 125 mg tablet (generic)
| Strength and form | Brand or generic | Pharmacy cost | 30 tablets, or one pen or vial | 12-month change |
|---|---|---|---|---|
| Griseofulvin 125 mg/5 mL suspension | Generic | $0.252 per mL | n/a | -13% |
| Griseofulvin micro 500 mg tablet | Generic | $5.85 per tablet | $175.41 | -9% |
| Griseofulvin ultra 125 mg tablet | Generic | $2.65 per tablet | $79.55 | -20% |
| Griseofulvin ultra 250 mg tablet | Generic | $3.74 per tablet | $112.24 | -12% |
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What does the griseofulvin label say about other medicines?
The griseofulvin label names no other medicine on this site. The labels of 21 other medicines name griseofulvin. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
Other labels that name griseofulvin
- Aminolevulinic acid
- Dienogest and estradiol
- Drospirenone
- Ethinyl estradiol and ferrous bisglycinate and levonorgestrel
- Ethinyl estradiol and ferrous fumarate and levonorgestrel
- Ethinyl estradiol and levonorgestrel
- Ethinyl estradiol and norelgestromin
- Ethinyl estradiol and norgestimate
- Etonogestrel
- Norethindrone
- Pentobarbital
- Porfimer
- Verteporfin
Source: FDA drug label (Ultramicrosize Griseofulvin), Chartwell RX, LLC., effective December 10, 2025 (SPL set efb8a660-802c-4ca6-bbff-ad7b48b91aef), via openFDA; the full label on DailyMed
What do FAERS reports show for griseofulvin?
The FDA Adverse Event Reporting System holds 286 reports that list griseofulvin among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 15 are coded as a death and 95 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What else is labeled for the same conditions as griseofulvin?
8 other medicines are given the same way (oral) and in the same FDA class as griseofulvin or labeled mainly for the same use (fungal infections), the same class first. Fungal infections lists all 33 medicines labeled for it, by any route. They are listed as records, not as substitutes: whether one can replace another is a prescriber's decision.
| Medicine | Shared indication | Generic labelers (oral) | Pharmacy cost | Shortage |
|---|---|---|---|---|
| Fluconazole | Fungal infections | 38 labelers | $0.380 per tablet 200 mg tablet | No current entry |
| Voriconazole | Fungal infections | 21 labelers | $1.88 per tablet 200 mg tablet | A presentation being discontinued |
| Terbinafine | Fungal infections | 22 labelers | $0.143 per tablet 250 mg tablet | No current entry |
| Nystatin | Fungal infections | 21 labelers | $0.0569 per mL 100,000 unit/mL suspension | No current entry |
| Posaconazole | Fungal infections | 21 labelers | $2.03 per tablet 100 mg tablet | A presentation being discontinued |
| Flucytosine | Fungal infections | 9 labelers | n/a | No current entry |
| Itraconazole | Fungal infections | 11 labelers | $0.910 per capsule 100 mg capsule | A presentation being discontinued |
| Clotrimazole | Fungal infections | 3 labelers | $0.292 per troche 10 mg troche | No current entry |
Source: FDA drug labels (indications), NDC Directory, NADAC of October 7, 2026, FDA shortages (October 8, 2026)
How does griseofulvin compare with medicines for the same use?
3 side-by-side pages set griseofulvin beside a medicine whose label shares a use: approvals, generics, pharmacy cost, warnings and supply.
What next?
- Griseofulvin side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other